Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track ...

A data analysis found the inhaled therapy Tyvaso outperformed a placebo at preserving lung function in people with IPF in a ...

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

The Walk for Hope will return for a second year to raise awareness and funds for research into pulmonary fibrosis.

KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, has discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs.

RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.

Nearly one million Israelis live with chronic lung diseases such as asthma and COPD, and for them the current security reality, which has already lasted almost two weeks, may worsen their condition.

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.